DLH (NASDAQ:DLHC) Downgraded by Zacks Research to Strong Sell

Zacks Research cut shares of DLH (NASDAQ:DLHC) from a hold rating to a strong sell rating in a research note published on Wednesday,Zacks.com reports.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of DLH in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Sell rating, According to data from MarketBeat, DLH currently has an average rating of “Sell”.

DLH Trading Down 1.1%

DLHC opened at $5.56 on Wednesday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.00 and a current ratio of 1.00. The stock’s 50 day moving average price is $5.89 and its 200-day moving average price is $5.70. DLH has a one year low of $2.72 and a one year high of $8.45. The stock has a market cap of $80.56 million, a price-to-earnings ratio of 55.61 and a beta of 1.56.

DLH (NASDAQ:DLHC) last issued its quarterly earnings results on Wednesday, December 10th. The business services provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.08). The business had revenue of $81.16 million for the quarter, compared to the consensus estimate of $83.50 million. DLH had a return on equity of 1.21% and a net margin of 0.40%.During the same period in the prior year, the business posted $0.16 earnings per share. On average, equities analysts forecast that DLH will post -0.13 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Mink Brook Asset Management Ll bought 44,208 shares of the stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of $5.50 per share, for a total transaction of $243,144.00. Following the acquisition, the insider owned 1,931,447 shares of the company’s stock, valued at $10,622,958.50. This represents a 2.34% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders acquired 59,498 shares of company stock worth $327,239. Insiders own 15.30% of the company’s stock.

Institutional Trading of DLH

Several institutional investors and hedge funds have recently made changes to their positions in DLHC. Nuveen LLC bought a new position in DLH during the 1st quarter worth about $44,000. Bank of America Corp DE lifted its position in shares of DLH by 31.9% in the 4th quarter. Bank of America Corp DE now owns 7,679 shares of the business services provider’s stock worth $62,000 after purchasing an additional 1,855 shares during the period. Jane Street Group LLC bought a new position in shares of DLH during the second quarter valued at approximately $65,000. Qube Research & Technologies Ltd purchased a new position in DLH during the second quarter valued at approximately $73,000. Finally, Quadrature Capital Ltd bought a new position in DLH in the second quarter worth approximately $89,000. 67.25% of the stock is currently owned by institutional investors.

DLH Company Profile

DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), the Defense Health Agency, Tele-medicine and Advanced Technology Research Center, and US Navy Naval Information Warfare Center (NIWC).